Intermune PIPF – 016

The PI of this project was: Keith Meyer, MD

This project was funded by: Sponsor

The term of this project was: December 2011 to June 2013

The number of subjects scanned during this project was: 10

To confirm the effect of pirfenidine on reducing the decline in lung function observed in previous studies. Primary endpoint will be change in % FVC from Day 1 to Week 52.